Popular Articles

Total Confirmed Human Swine Flu Cases Jumps To 4,250 In The UK
An additional 535 confirmed human cases of Swine Flu A(H1N1) cases have been confirmed in the England, plus 111 in Scotland, 5 in Northern Ireland, and 3 in Wales, bringing the UK total so far since April 2009 to 4,250, says the Health Protection Agency (HPA). The HPA informs that the infection can be effectively treated with antiviral medication. The majority of UK cases have been mild, the agency says, and people have recovered fully after treatment.
buy viagra
John Muir Health Foundation Funds Advanced Robotic Technology For Minimally Invasive Surgery
John Muir Health Foundation, the charitable fundraising organization for all John Muir Health programs and services, has provided funding to enable John Muir Health to purchase two advanced high definition daVinci® Surgical Systems for its Walnut Creek and Concord campuses. Surgeons at John Muir Heath will use the daVinci® "robots" for a variety of minimally invasive urological, gynecological, gynecologic/oncologic and colorectal treatments.
News of the day
Timing Is Everything: Growth Factor Keeps Brain Development On Track
Just like a conductor cueing musicians in an orchestra, Fgf10, a member of the fibroblast growth factor (Ffg) family of morphogens, lets brain stem cells know that the moment to get to work has arrived, ensuring that they hit their first developmental milestone on time, report scientists at the Salk Institute for Biological Studies in the July 16, 2009, edition of the journal Neuron.
Medical Devices

PARI LC Plus And PRONEB Ultra Used In Two Perforomist Studies On Improving COPD Therapies

In two recent COPD studies sponsored by DEY LP, PARI"s LC Plus nebulizer and PRONEB compressors (Ultra and Ultra II) were used to show that nebulized formoterol fumarate (Perforomist, DEY LP, Mylan Inc.) improves pulmonary function. "We are pleased that researchers chose PARI products as the exclusive nebulizer systems for recent studies comparing maintenance treatments for COPD. Sutherland et al. used an open-label crossover design allowing researchers to catalog patient preferences regarding medication delivery. Patients felt greater treatment satisfaction and perceived better control of their COPD with nebulized formoterol fumarate delivered by PARI"s LC Plus and PRONEB Ultra II. These results are consistent with other studies," said Lisa Cambridge, RRT, director of clinical development at PARI Respiratory Equipment. The Sutherland et al. study, published in Current Medical Research and Opinion, compared nebulized formoterol fumarate to ipratropium/albuterol delivered via a metered dose inhaler. The study concluded that nebulized formoterol fumarate significantly improved pulmonary function and was more satisfactory to COPD patients than treatment with ipratropium/albuterol delivered via MDI. The Tashkin et al. study, presented at the American Thoracic Society conference last month, looked at the effectiveness of adding nebulized formoterol fumarate, delivered via PARI"s LC Plus and PRONEB Ultra, to maintenance tiotropium compared to placebo/tiotropium. The study concluded that adding nebulized formoterol fumarate to maintenance tiotropium in COPD subjects provided significant improvements in pulmonary function, dyspnea, and rescue albuterol use over tiotropium alone. The incidence of adverse events was lower during treatment with formoterol/tiotropium compared to placebo/tiotropium. The PARI LC Plus nebulizer and PARI PRONEB Ultra compressor were used exclusively in pivotal clinical trials for Perforomist Inhalation Solution and are listed in the package insert. About PARI Respiratory Equipment, Inc. PARI is a leading worldwide developer and manufacturer of fast and efficient aerosol delivery systems for patients with asthma, chronic lung disease, and cystic fibrosis. PARI"s worldwide vision is to improve the lives of those affected by respiratory diseases and those who care for them. Maker of the world"s leading breath-enhanced reusable nebulizer, the PARI LC PLUS, and the new PARI LC Sprint nebulizer line, PARI also manufactures the award winning PARI TREK S compact compressor, Bubbles the Fish II aerosol mask, and durable PARI PRONEB Ultra II. PARI"s Vortex anti-static valved holding chamber improves the aerosol deposition of metered dose inhalers (MDIs) PARI Respiratory Equipment, Inc


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):